propylene glycol and melphalan

propylene glycol has been researched along with melphalan in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aljitawi, OS; Allen, LF; Arce-Lara, C; Bhat, G; Callander, N; Hari, P; Nath, R; Stockerl-Goldstein, K1
Bergren, M; Chen, J; Mallik, R; Miller, T; Singh, R1
Badar, T; Chhabra, S; D'Souza, A; Dhakal, B; Drobyski, WR; Fenske, TS; Hamadani, M; Hari, P; Pasquini, M; Saber, W; Shah, NN; Shaw, BE1
Glotzbecker, B; Laubach, J; McDonnell, AM; Ni, J; Soiffer, R; Xiang, E1

Trials

1 trial(s) available for propylene glycol and melphalan

ArticleYear
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:12

    Topics: Adult; Aged; Cyclodextrins; Drug Administration Schedule; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Myeloablative Agonists; Propylene Glycol; Severity of Illness Index; Solubility; Stomatitis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2015

Other Studies

3 other study(ies) available for propylene glycol and melphalan

ArticleYear
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
    Pharmaceutical development and technology, 2018, Volume: 23, Issue:10

    Topics: Antineoplastic Agents, Alkylating; beta-Cyclodextrins; Drug Contamination; Drug Stability; Excipients; Injections; Melphalan; Pharmaceutical Solutions; Propylene Glycol

2018
Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective.
    Bone marrow transplantation, 2018, Volume: 53, Issue:9

    Topics: Adult; Aged; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Melphalan; Middle Aged; Propylene Glycol; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2018
Evaluating the adverse effects of melphalan formulations.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cohort Studies; Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Propylene Glycol; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2019